UNH vs V: Which Is the Better Buy?

Side-by-side comparison of UnitedHealth Group Incorporated and Visa Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-11.
UnitedHealth Group Incorporated Β· Healthcare
$304.33
+41.3% upside to fair value
Med Conviction Grade B+
VS
Visa Inc. Β· Financial Services
$304.36
+37.7% upside to fair value
High Conviction Grade A-
QuantHub Verdict
UNH has more upside to fair value (+41.3%). UNH trades at a lower forward P/E (15.1x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric UNH V
Current Price $304.33 $304.36
Fair Value Estimate $430.00 $419.00
Upside to Fair Value +41.3% +37.7%
Market Cap $276.2B $586.8B
Forward P/E 15.1x 23.7x
EV / EBITDA 14.3x 22.3x
Price / Sales 0.6x 14.2x
Price / FCF 17.2x 25.6x
Revenue Growth YoY +11.8% +11.3%
Gross Margin 18.5% 81.08%
Operating Margin 4.2% 59.18%
Return on Equity 12.7% 54.22%
Dividend Yield 2.9% 0.83%
FCF Yield 5.82% 3.91%
Analyst Consensus Buy Strong Buy
Investment Thesis
UNH β€” UnitedHealth Group Incorporated
UnitedHealth Group is the world's largest diversified healthcare company, combining the dominant US health insurer UnitedHealthcare with the high-margin Optum services platform spanning care delivery, pharmacy benefits, and data analytics. The stock has fallen roughly 49% from its 2024 peak of $596, driven by elevated medical costs, DOJ antitrust scrutiny, CEO transitions (Brian Thompson's murder…
V β€” Visa Inc.
Visa is the world's dominant payment network with $40B in net revenue (FY2025), 50%+ net margins, and a capital-light toll-booth model processing $14.2T in annual payment volume across 257.5B transactions. The business compounds at 10-12% revenue CAGR with operating leverage pushing EPS growth to 12-15% over a cycle, funded by $21.6B in annual free cash flow against only $1.5B in capex. At 28.0x …
Accumulation Zones
Metric UNH V
Zone Low $280.00 $265.00
Zone High $340.00 $300.00
In Buy Zone? Yes No
← UNH Research    V Research β†’    All Research